doi: 10.3389/fimmu.2024.1440313 Received 30 May 2024 Accepted 18 November 2024 Published 05 December 2024 Volume 15 - 2024 Edited by Xing Wang, The Affiliated Hospital of Southwest Medical University, China Reviewed by Christoph Hudemann, Philipps-University Marburg, Germany Franziska Roth-Walter, University of Veterinary Medicine Vienna, Austria Updates Copyright 2024 Biedrzycki, Wolszczak-Biedrzycka, Dorf and Maciejczyk
Benefcios adicionais da X-Carnitina
Regulatory status: Neither peptide is FDA-approved, and both are banned for competitive athletes by WADA
Strength points and limitations Based on our knowledge, this is the most updated meta-analysis on this topic, including all available evidence based on our inclusion criteria of including only controlled studies, either RCTs or controlled observational studies, to reach the highest accessible quality of evidence from the available evidence found in the literature